<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="2.3" xml:lang="EN"><front><journal-meta><journal-id journal-id-type="publisher-id">IMR</journal-id><journal-id journal-id-type="hwp">spimr</journal-id><journal-title>Journal of International Medical Research</journal-title><issn pub-type="ppub">0300-0605</issn><issn pub-type="epub">1473-2300</issn><publisher><publisher-name>SAGE Publications</publisher-name><publisher-loc>Sage UK: London, England</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.1177/0300060513477290</article-id><article-id pub-id-type="publisher-id">10.1177_0300060513477290</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Note</subject></subj-group></article-categories><title-group><article-title>Increasing age associated with elevated cardio–ankle vascular index scores in patients with type 2 diabetes mellitus</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Tian</surname><given-names>Guoxiang</given-names></name><xref ref-type="aff" rid="aff1-0300060513477290">1</xref></contrib><contrib contrib-type="author" corresp="yes" xlink:type="simple"><name name-style="western"><surname>Wei</surname><given-names>Wanlin</given-names></name><xref ref-type="aff" rid="aff1-0300060513477290">1</xref><xref ref-type="corresp" rid="corresp1-0300060513477290"/></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Zhang</surname><given-names>Wei</given-names></name><xref ref-type="aff" rid="aff2-0300060513477290">2</xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Zhang</surname><given-names>Ling</given-names></name><xref ref-type="aff" rid="aff2-0300060513477290">2</xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>You</surname><given-names>Hongshuai</given-names></name><xref ref-type="aff" rid="aff1-0300060513477290">1</xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Liu</surname><given-names>Wen</given-names></name><xref ref-type="aff" rid="aff3-0300060513477290">3</xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Sun</surname><given-names>Zhu</given-names></name><xref ref-type="aff" rid="aff1-0300060513477290">1</xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Wang</surname><given-names>Xiaobing</given-names></name><xref ref-type="aff" rid="aff2-0300060513477290">2</xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Wu</surname><given-names>Xiao</given-names></name><xref ref-type="aff" rid="aff2-0300060513477290">2</xref></contrib></contrib-group><aff id="aff1-0300060513477290"><label>1</label>Department of Cardiology, General Hospital of Beijing Military Command, Beijing, China</aff><aff id="aff2-0300060513477290"><label>2</label>Department of 4<sup>th</sup> Cadres Ward, General Hospital of Beijing Military Command, Beijing, China</aff><aff id="aff3-0300060513477290"><label>3</label>Department of Medical Engineering, General Hospital of Beijing Military Command, Beijing, China</aff><author-notes><corresp id="corresp1-0300060513477290">Dr Wanlin Wei, Department of Cardiology, General Hospital of Beijing Military Command, 813 Xilou (West Building), 5 Nanmencang Hutong, Dongsishitiao, Dongcheng District, Beijing 100700, China. Email: <email xlink:type="simple">weiwanlin2011@126.com</email></corresp></author-notes><pub-date pub-type="epub-ppub"><month>4</month><year>2013</year></pub-date><volume>41</volume><issue>2</issue><fpage>435</fpage><lpage>444</lpage><history><date date-type="received"><day>19</day><month>9</month><year>2012</year></date><date date-type="accepted"><day>2</day><month>12</month><year>2012</year></date></history><permissions><copyright-statement>© The Author(s) 2013 Reprints and permissions: sagepub.co.uk/journalsPermissions.nav</copyright-statement><copyright-year>2013</copyright-year><copyright-holder content-type="sage">SAGE Publications</copyright-holder></permissions><abstract><sec id="sec15-0300060513477290"><title>Objective</title><p>The study investigated the relationship between arterial stiffness calculated using the cardio–ankle vascular index (CAVI), diagnosis of type 2 diabetes mellitus and type 2 diabetes-related cardiovascular complications, in patients with type 2 diabetes mellitus (type 2 diabetes) and nondiabetic patients.</p></sec><sec id="sec16-0300060513477290"><title>Methods</title><p>A retrospective cross-sectional study was conducted in patients with type 2 diabetes and age-matched nondiabetic patients. CAVI was measured using an automatic vascular screening system. Parameters associated with type 2 diabetes and cardiovascular complications were also measured.</p></sec><sec id="sec17-0300060513477290"><title>Results</title><p>A total of 51 patients with type 2 diabetes and 59 nondiabetic patients were enrolled in the study. Significantly higher CAVI scores were observed in patients with type 2 diabetes compared with nondiabetic patients (mean ± SD: 9.55 ± 1.13 versus 8.54 ± 0.94, respectively). Multivariate linear regression analyses demonstrated that age was the only significant factor influencing the CAVI score, in patients with type 2 diabetes.</p></sec><sec id="sec18-0300060513477290"><title>Conclusion</title><p>Patients with type 2 diabetes had an increased risk of arterial stiffness, based on the CAVI score, compared with nondiabetic patients; this, in turn, could increase their risk of developing other cardiovascular complications.</p></sec></abstract><kwd-group><kwd>Type 2 diabetes mellitus</kwd><kwd>cardio–ankle vascular index</kwd><kwd>hypertension</kwd><kwd>arterial stiffness</kwd></kwd-group></article-meta></front><body><sec id="sec1-0300060513477290" sec-type="intro"><title>Introduction</title><p>Type 2 diabetes mellitus (type 2 diabetes) is a metabolic disease characterized by a high blood glucose level and insulin deficiency, accompanied by atherosclerotic macrovascular cardiovascular complications such as arterial endothelial dysfunction, vascular smooth-muscle proliferation, thrombogenesis and proatherogenic cellular processes.<sup><xref ref-type="bibr" rid="bibr1-0300060513477290">1</xref><xref ref-type="bibr" rid="bibr2-0300060513477290"/>–<xref ref-type="bibr" rid="bibr3-0300060513477290">3</xref></sup> Chronic hyperglycaemia and hyperinsulinaemia can increase local activity of the renin–angiotensin–aldosterone system, resulting in increased vascular tissue expression of angiotensin II receptor type I,<sup><xref ref-type="bibr" rid="bibr4-0300060513477290">4</xref></sup> promoting cardiovascular wall hypertrophy and fibrosis.<sup><xref ref-type="bibr" rid="bibr5-0300060513477290">5</xref>,<xref ref-type="bibr" rid="bibr6-0300060513477290">6</xref></sup> Nonenzymatic protein glycation can further alter the mechanical properties of interstitial tissues,<sup><xref ref-type="bibr" rid="bibr7-0300060513477290">7</xref></sup> increasing large elastic artery stiffness associated with cardiovascular disease in patients with type 2 diabetes.<sup><xref ref-type="bibr" rid="bibr8-0300060513477290">8</xref><xref ref-type="bibr" rid="bibr9-0300060513477290"/>–<xref ref-type="bibr" rid="bibr10-0300060513477290">10</xref></sup> Increased arterial stiffness has been suggested as a predictive factor for cardiovascular disease that requires further exploration in patients with type 2 diabetes.<sup><xref ref-type="bibr" rid="bibr11-0300060513477290">11</xref></sup></p><p>The cardio–ankle vascular index (CAVI) was developed as the successor to Bramwell’s original technically complex pulse wave velocity (PWV) method for the evaluation of aortic stiffness, by combining a stiffness parameter β and the Bramwell-Hill’s formula.<sup><xref ref-type="bibr" rid="bibr12-0300060513477290">12</xref>,<xref ref-type="bibr" rid="bibr13-0300060513477290">13</xref></sup> CAVI has since been demonstrated to be superior to brachial-ankle pulse wave velocity (baPWV),<sup><xref ref-type="bibr" rid="bibr14-0300060513477290">14</xref>,<xref ref-type="bibr" rid="bibr15-0300060513477290">15</xref></sup> and to show a close association with cardiovascular conditions including coronary atherosclerosis, carotid intima–media thickness and homocysteine levels.<sup><xref ref-type="bibr" rid="bibr16-0300060513477290">16</xref>,<xref ref-type="bibr" rid="bibr17-0300060513477290">17</xref></sup> CAVI measurements have also been associated with the presence of microvascular complications in patients with type 2 diabetes.<sup><xref ref-type="bibr" rid="bibr14-0300060513477290">14</xref>,<xref ref-type="bibr" rid="bibr18-0300060513477290">18</xref></sup> While drug therapies (such as glimepiride) can improve CAVI in patients with type 2 diabetes,<sup><xref ref-type="bibr" rid="bibr19-0300060513477290">19</xref></sup> the mechanism of action requires further study in patients with type 2 diabetes.</p><p>The current study investigated the relationship between arterial stiffness calculated using CAVI scoring methods, a diagnosis of type 2 diabetes, and type 2 diabetes-related cardiovascular complications in patients with type 2 diabetes and nondiabetic patients, in order to identify any risk factors associated with an increased CAVI score and evaluate potential pathological mechanisms involved in the development of cardiovascular complications in these patient groups.</p></sec><sec id="sec2-0300060513477290" sec-type="methods"><title>Patients and methods</title><sec id="sec3-0300060513477290" sec-type="subjects"><title>Patient population</title><p>This retrospective cross-sectional study enrolled consecutive outpatients with type 2 diabetes attending the Department of 4<sup>th</sup> Cadres Ward, General Hospital of the Beijing Military Command, Beijing, China for treatment between June 2008 and July 2010. A diagnosis of type 2 diabetes was made using the American Diabetes Association (2003) standard.<sup><xref ref-type="bibr" rid="bibr20-0300060513477290">20</xref></sup></p><p>Patients with type 2 diabetes met the following inclusion criteria: (i) ages 30–70 years; (ii) presence of complete diabetic complication workups using CAVI and ankle–brachial index (ABI); (iii) successful completion of a same-day 24-h urine collection test for albuminuria and proteinuria. This study also recruited age-matched nondiabetic patients who were inpatients in the same department at the same time, who met the criteria above, to serve as the control group.</p><p>Exclusion criteria for all study participants were: (i) overt macroalbuminuria, defined as a 24-h urinary albumin excretion ≥ 300 mg/day; (ii) angina; (iii) acute myocardial infarction or pulmonary heart disease; (iv) significant valvular disease, including atrial fibrillation or abnormal left ventricular ejection fraction (&lt;50%); (v) prior cerebrovascular accident(s); (vi) renal insufficiency; (vii) a history of peripheral artery disease; (viii) ABI &lt; 0.9; (ix) current acute infectious disease; (x) nonaffiliation with the hospital. Cardiovascular complications were not excluded.</p><p>Hypertension was diagnosed in all participants using the World Health Organization – International Society of Hypertension Guidelines for the Management of Hypertension (1999) standards.<sup><xref ref-type="bibr" rid="bibr21-0300060513477290">21</xref></sup> Antihypertensive drug use was recorded. Coronary heart disease was diagnosed according to criteria produced by the Joint International Society and Federation of Cardiology and the World Health Organization (1979).<sup><xref ref-type="bibr" rid="bibr22-0300060513477290">22</xref></sup> Left ventricular ejection fraction was assessed by 2-D echocardiography using the biplane Simpson method. Smoking and alcohol consumption habits were recorded for all study participants.</p><p>The study protocol was approved by the Ethics Committee of the General Hospital of the Beijing Military Command, consistent with the Declaration of Helsinki (reference number: 004). All study participants provided written informed consent.</p></sec><sec id="sec4-0300060513477290"><title>Laboratory measurements</title><p>On the second day as inpatients, blood samples were collected after a 12-h fast from the ulnar vein of each patient for the analysis of blood cholesterol, glucose and insulin levels. Before analysis, blood samples were kept at room temperature for 1.5 h, then they were centrifuged at approximately 88 g for 10 min, at room temperature. Serum was collected and stored at –80°C. Fasting serum total cholesterol, high-density lipoprotein cholesterol (HDL-C), triglyceride, and blood glucose levels were measured using an automated clinical analyser (Hitachi 7600-020; Hitachi High-Technologies, Tokyo, Japan). Low-density lipoprotein cholesterol (LDL-C) levels were calculated according to the Friedewald formula (LDL-C = total cholesterol – HDL-C – 1/5 triglycerides, where serum triglyceride levels are ≤ 400 mg/dl).<sup><xref ref-type="bibr" rid="bibr23-0300060513477290">23</xref></sup> Serum insulin concentrations were evaluated by radioimmunoassay (CMK-004; Beijing Atom High Tech, Beijing, China). Whole-blood glycosylated haemoglobin (HbA<sub>1c</sub>) levels were measured using a latex-enhanced immunoturbidimetric assay with a clinical analyser (Hitachi 7600-020; Hitachi). Insulin resistance was estimated using the homeostasis model assessment of insulin resistance as follows: fasting serum insulin (mU/l) × fasting blood glucose (mmol/l)/22.5.<sup><xref ref-type="bibr" rid="bibr24-0300060513477290">24</xref></sup> Body mass index (BMI) was obtained using the ratio of weight (kg) to height squared (m<sup>2</sup>).</p></sec><sec id="sec5-0300060513477290"><title>CAVI score</title><p>The CAVI score was measured using an automatic vascular screening system (VaSera VS-1000; Fukuda Denshi, Tokyo, Japan) from measurements of blood pressure and PWV. Patients were resting in a supine position during the CAVI measurements. All measurements were conducted under continuous electrocardiogram and heart sound monitoring.<sup><xref ref-type="bibr" rid="bibr25-0300060513477290">25</xref>,<xref ref-type="bibr" rid="bibr26-0300060513477290">26</xref></sup> PWV was calculated by dividing the distance from the aortic valve to the ankle artery by the sum of the time between the aortic valve closing sound and the notch of the brachial pulse wave, and the time between the rise of the brachial pulse wave and the rise of the ankle pulse wave. CAVI was determined using the following equation: CAVI = <italic>a</italic>[(2ρ/ΔP) × ln (<italic>Ps</italic>/<italic>Pd</italic>) PWV<sup><xref ref-type="bibr" rid="bibr2-0300060513477290">2</xref></sup>] + <italic>b,</italic> where <italic>Ps</italic> and <italic>Pd</italic> are systolic and diastolic blood pressure, respectively, PWV is the pulse wave velocity between the heart and ankle, ΔP is <italic>Ps</italic> – <italic>Pd</italic>; ρ is blood density; and <italic>a</italic> and <italic>b</italic> are scale conversion constants to match aortic PWV. The mean value of the right and left CAVI score for each patient was used for analysis.</p></sec><sec id="sec6-0300060513477290"><title>Statistical analyses</title><p>All statistical analyses were performed using the SPSS® statistical package, version 13.0 (SPSS Inc., Chicago, IL, USA) for Windows®. Continuous variables are presented as mean ± SD. An unpaired Student’s <italic>t</italic>-test was used for comparing continuous variables between patients with type 2 diabetes and the nondiabetic patients. Categorical variables were compared between the two groups using χ<sup>2</sup>-test. Factors independently associated with CAVI were assessed using univariate and multivariate linear regression analyses. A <italic>P</italic>-value &lt; 0.05 was considered statistically significant.</p></sec></sec><sec id="sec7-0300060513477290" sec-type="results"><title>Results</title><p>A total of 51 patients with type 2 diabetes and 59 nondiabetic patients were enrolled in the study. Their demographic and clinical characteristics are presented in <xref ref-type="table" rid="table1-0300060513477290">Table 1</xref>. There were no significant differences between the two groups in terms of sex, age, smoking prevalence, alcohol consumption, presence of coronary heart disease, total cholesterol, LDL-C or HDL-C levels, or left ventricular ejection fraction. Hypertension was significantly more prevalent in the type 2 diabetes group compared with the nondiabetic group (<italic>P</italic> = 0.02). The following variables were all significantly higher in patients with type 2 diabetes than in nondiabetic patients: triglycerides, fasting blood glucose, HbA<sub>1c</sub>, heart rate and BMI (<italic>P</italic> &lt; 0.05, all comparisons). The mean CAVI score was significantly higher in patients with type 2 diabetes compared with the nondiabetic patients (<italic>P</italic> &lt; 0.001). A significantly higher proportion of patients with type 2 diabetes exhibited increased aortic stiffness based on a CAVI score &gt; 9.1 compared with the nondiabetic patients (<italic>P</italic> = 0.003).<table-wrap id="table1-0300060513477290" position="float"><label>Table 1.</label><caption><p>Demographic and clinical characteristics of participants in a study investigating the relationship between arterial stiffness and cardiovascular complications in patients with or without type 2 diabetes mellitus.</p></caption><graphic alt-version="no" alternate-form-of="table1-0300060513477290" position="float" xlink:href="10.1177_0300060513477290-table1.tif" xlink:type="simple"/><table frame="hsides"><thead align="left"><tr><th colspan="1" rowspan="1">Parameter</th><th colspan="1" rowspan="1">Patients with type 2 diabetes mellitus <italic>n</italic> = 51</th><th colspan="1" rowspan="1">Nondiabetic patients <italic>n</italic> = 59</th><th colspan="1" rowspan="1">Statistical significance<sup><xref ref-type="table-fn" rid="table-fn2-0300060513477290">a</xref></sup></th></tr></thead><tbody align="left"><tr><td colspan="4" rowspan="1">Sex</td></tr><tr><td colspan="1" rowspan="1"> Male</td><td colspan="1" rowspan="1">29 (56.9)</td><td colspan="1" rowspan="1">28 (47.5)</td><td colspan="1" rowspan="2">NS</td></tr><tr><td colspan="1" rowspan="1"> Female</td><td colspan="1" rowspan="1">22 (43.1)</td><td colspan="1" rowspan="1">31 (52.5)</td></tr><tr><td colspan="4" rowspan="1">Age, years</td></tr><tr><td colspan="1" rowspan="1"> &lt; 50</td><td colspan="1" rowspan="1">2 (3.9)</td><td colspan="1" rowspan="1">5 (8.5)</td><td colspan="1" rowspan="4">NS</td></tr><tr><td colspan="1" rowspan="1"> 50–59</td><td colspan="1" rowspan="1">13 (25.5)</td><td colspan="1" rowspan="1">18 (30.5)</td></tr><tr><td colspan="1" rowspan="1"> 60–69</td><td colspan="1" rowspan="1">11 (21.6)</td><td colspan="1" rowspan="1">16 (27.1)</td></tr><tr><td colspan="1" rowspan="1"> ≥ 70</td><td colspan="1" rowspan="1">25 (49.0)</td><td colspan="1" rowspan="1">20 (33.9)</td></tr><tr><td colspan="4" rowspan="1">Smoking</td></tr><tr><td colspan="1" rowspan="1"> No</td><td colspan="1" rowspan="1">11 (21.6)</td><td colspan="1" rowspan="1">22 (37.3)</td><td colspan="1" rowspan="2">NS</td></tr><tr><td colspan="1" rowspan="1"> Yes</td><td colspan="1" rowspan="1">40 (78.4)</td><td colspan="1" rowspan="1">37 (62.7)</td></tr><tr><td colspan="4" rowspan="1">Alcohol consumption</td></tr><tr><td colspan="1" rowspan="1"> No</td><td colspan="1" rowspan="1">44 (86.3)</td><td colspan="1" rowspan="1">43 (72.9)</td><td colspan="1" rowspan="2">NS</td></tr><tr><td colspan="1" rowspan="1"> Yes</td><td colspan="1" rowspan="1">7 (13.7)</td><td colspan="1" rowspan="1">16 (27.1)</td></tr><tr><td colspan="4" rowspan="1">Hypertension</td></tr><tr><td colspan="1" rowspan="1"> No</td><td colspan="1" rowspan="1">7 (13.7)</td><td colspan="1" rowspan="1">19 (32.2)</td><td colspan="1" rowspan="2"><italic>P</italic> = 0.02</td></tr><tr><td colspan="1" rowspan="1"> Yes</td><td colspan="1" rowspan="1">44 (86.3)</td><td colspan="1" rowspan="1">40 (67.8)</td></tr><tr><td colspan="4" rowspan="1">Coronary heart disease</td></tr><tr><td colspan="1" rowspan="1"> No</td><td colspan="1" rowspan="1">26 (51.0)</td><td colspan="1" rowspan="1">33 (55.9)</td><td colspan="1" rowspan="2">NS</td></tr><tr><td colspan="1" rowspan="1"> Yes</td><td colspan="1" rowspan="1">25 (49.0)</td><td colspan="1" rowspan="1">26 (44.1)</td></tr><tr><td colspan="4" rowspan="1">CAVI score</td></tr><tr><td colspan="1" rowspan="1"> ≤ 9.1</td><td colspan="1" rowspan="1">21 (41.2)</td><td colspan="1" rowspan="1">41 (69.5)</td><td colspan="1" rowspan="2"><italic>P</italic> = 0.003</td></tr><tr><td colspan="1" rowspan="1"> &gt; 9.1</td><td colspan="1" rowspan="1">30 (58.8)</td><td colspan="1" rowspan="1">18 (30.5)</td></tr><tr><td colspan="1" rowspan="1">CAVI score</td><td colspan="1" rowspan="1">9.55 ± 1.13</td><td colspan="1" rowspan="1">8.54 ± 0.94</td><td colspan="1" rowspan="1"><italic>P</italic> &lt; 0.001</td></tr><tr><td colspan="1" rowspan="1">TC, mmol/l</td><td colspan="1" rowspan="1">4.75 ± 0.94</td><td colspan="1" rowspan="1">4.89 ± 1.06</td><td colspan="1" rowspan="1">NS</td></tr><tr><td colspan="1" rowspan="1">TG, mmol/l</td><td colspan="1" rowspan="1">2.29 ± 1.39</td><td colspan="1" rowspan="1">1.76 ± 0.99</td><td colspan="1" rowspan="1"><italic>P</italic> = 0.03</td></tr><tr><td colspan="1" rowspan="1">LDL-C, mmol/l</td><td colspan="1" rowspan="1">3.08 ± 0.62</td><td colspan="1" rowspan="1">3.14 ± 0.65</td><td colspan="1" rowspan="1">NS</td></tr><tr><td colspan="1" rowspan="1">HDL-C, mmol/l</td><td colspan="1" rowspan="1">1.38 ± 0.24</td><td colspan="1" rowspan="1">1.42 ± 0.31</td><td colspan="1" rowspan="1">NS</td></tr><tr><td colspan="1" rowspan="1">FBG, mmol/l</td><td colspan="1" rowspan="1">8.59 ± 2.84</td><td colspan="1" rowspan="1">5.34 ± 0.63</td><td colspan="1" rowspan="1"><italic>P</italic> &lt; 0.0001</td></tr><tr><td colspan="1" rowspan="1">HbA<sub>1c</sub>, %</td><td colspan="1" rowspan="1">8.72 ± 1.84</td><td colspan="1" rowspan="1">6.63 ± 0.80</td><td colspan="1" rowspan="1"><italic>P</italic> &lt; 0.0001</td></tr><tr><td colspan="1" rowspan="1">LVEF, %</td><td colspan="1" rowspan="1">65.84 ± 7.95</td><td colspan="1" rowspan="1">66.36 ± 6.14</td><td colspan="1" rowspan="1">NS</td></tr><tr><td colspan="1" rowspan="1">HR, beats/min</td><td colspan="1" rowspan="1">74.80 ± 12.84</td><td colspan="1" rowspan="1">69.81 ± 12.35</td><td colspan="1" rowspan="1"><italic>P</italic> = 0.04</td></tr><tr><td colspan="1" rowspan="1">BMI, kg/m<sup>2</sup></td><td colspan="1" rowspan="1">25.95 ± 3.55</td><td colspan="1" rowspan="1">24.53 ± 3.50</td><td colspan="1" rowspan="1"><italic>P</italic> = 0.04</td></tr></tbody></table><table-wrap-foot><fn id="table-fn1-0300060513477290"><p>Data presented as mean ± SD or <italic>n</italic> (%) of patients.</p></fn><fn id="table-fn2-0300060513477290"><label>a</label><p><italic>P</italic> &lt; 0.05; continuous variables between the two groups were compared using an unpaired Student’s <italic>t</italic>-test; categorical variables were compared between the two groups using χ<sup>2</sup>-test.</p></fn><fn id="table-fn3-0300060513477290"><p>CAVI, cardio–ankle vascular index; TC, total cholesterol; TG, triglycerides; LDL-C, low-density lipoprotein cholesterol; HDL-C, high-density lipoprotein cholesterol; FBG, fasting blood glucose; HbA<sub>1c</sub>, glycosylated haemoglobin; LVEF, left ventricular ejection fraction; HR, heart rate; BMI, body mass index; NS, not statistically significant (<italic>P</italic> ≥ 0.05).</p></fn></table-wrap-foot></table-wrap></p><p>Subgroup analyses of patients with type 2 diabetes, stratified according to different clinical parameters, demonstrated that an increased CAVI score had a significant association with increasing age, particularly in patients aged ≥ 70 years, smokers, those who consumed alcohol and those with a total cholesterol level ≥ 5.2 mmol/l (all <italic>P</italic> &lt; 0.05; <xref ref-type="table" rid="table2-0300060513477290">Table 2</xref>). Increasing age was most significantly correlated with an increased CAVI.<table-wrap id="table2-0300060513477290" position="float"><label>Table 2.</label><caption><p>Subgroup analyses showing cardio–ankle vascular index (CAVI) scores for patients with type 2 diabetes, stratified according to different clinical parameters (<italic>n</italic> = 51).</p></caption><graphic alt-version="no" alternate-form-of="table2-0300060513477290" position="float" xlink:href="10.1177_0300060513477290-table2.tif" xlink:type="simple"/><table frame="hsides"><thead align="left"><tr><th colspan="1" rowspan="1">Parameter</th><th colspan="1" rowspan="1"><italic>n</italic></th><th colspan="1" rowspan="1">CAVI</th><th colspan="1" rowspan="1">Statistical significance<sup><xref ref-type="table-fn" rid="table-fn5-0300060513477290">a</xref></sup></th></tr></thead><tbody align="left"><tr><td colspan="4" rowspan="1">Sex</td></tr><tr><td colspan="1" rowspan="1"> Male</td><td colspan="1" rowspan="1">22</td><td colspan="1" rowspan="1">9.64 ± 1.18</td><td colspan="1" rowspan="2">NS</td></tr><tr><td colspan="1" rowspan="1"> Female</td><td colspan="1" rowspan="1">29</td><td colspan="1" rowspan="1">9.42 ± 1.09</td></tr><tr><td colspan="4" rowspan="1">Age, years</td></tr><tr><td colspan="1" rowspan="1"> &lt; 50</td><td colspan="1" rowspan="1">2</td><td colspan="1" rowspan="1">7.83 ± 0.81</td><td colspan="1" rowspan="4"><italic>P</italic> = 0.002</td></tr><tr><td colspan="1" rowspan="1"> 50–59</td><td colspan="1" rowspan="1">13</td><td colspan="1" rowspan="1">8.90 ± 0.35</td></tr><tr><td colspan="1" rowspan="1"> 60–69</td><td colspan="1" rowspan="1">11</td><td colspan="1" rowspan="1">9.55 ± 1.23</td></tr><tr><td colspan="1" rowspan="1"> ≥ 70</td><td colspan="1" rowspan="1">25</td><td colspan="1" rowspan="1">10.01 ± 1.12</td></tr><tr><td colspan="4" rowspan="1">Smoking</td></tr><tr><td colspan="1" rowspan="1"> No</td><td colspan="1" rowspan="1">11</td><td colspan="1" rowspan="1">9.10 ± 0.60</td><td colspan="1" rowspan="2"><italic>P</italic> =  = 0.04</td></tr><tr><td colspan="1" rowspan="1"> Yes</td><td colspan="1" rowspan="1">40</td><td colspan="1" rowspan="1">9.67 ± 1.22</td></tr><tr><td colspan="4" rowspan="1">Alcohol consumption</td></tr><tr><td colspan="1" rowspan="1"> No</td><td colspan="1" rowspan="1">44</td><td colspan="1" rowspan="1">9.62 ± 1.19</td><td colspan="1" rowspan="2"><italic>P</italic> = 0.02</td></tr><tr><td colspan="1" rowspan="1"> Yes</td><td colspan="1" rowspan="1">7</td><td colspan="1" rowspan="1">9.05 ± 0.38</td></tr><tr><td colspan="4" rowspan="1">Hypertension</td></tr><tr><td colspan="1" rowspan="1"> No</td><td colspan="1" rowspan="1">7</td><td colspan="1" rowspan="1">9.09 ± 0.94</td><td colspan="1" rowspan="2">NS</td></tr><tr><td colspan="1" rowspan="1"> Yes</td><td colspan="1" rowspan="1">44</td><td colspan="1" rowspan="1">9.62 ± 1.15</td></tr><tr><td colspan="4" rowspan="1">Coronary heart disease</td></tr><tr><td colspan="1" rowspan="1"> No</td><td colspan="1" rowspan="1">26</td><td colspan="1" rowspan="1">9.60 ± 1.16</td><td colspan="1" rowspan="2">NS</td></tr><tr><td colspan="1" rowspan="1"> Yes</td><td colspan="1" rowspan="1">25</td><td colspan="1" rowspan="1">9.43 ± 1.13</td></tr><tr><td colspan="4" rowspan="1">TC, mmol/l<sup><xref ref-type="table-fn" rid="table-fn6-0300060513477290">b</xref></sup></td></tr><tr><td colspan="1" rowspan="1"> &lt; 5.2</td><td colspan="1" rowspan="1">34</td><td colspan="1" rowspan="1">9.28 ± 0.91</td><td colspan="1" rowspan="2"><italic>P</italic> = 0.007</td></tr><tr><td colspan="1" rowspan="1"> ≥ 5.2</td><td colspan="1" rowspan="1">16</td><td colspan="1" rowspan="1">10.18 ± 1.34</td></tr><tr><td colspan="4" rowspan="1">BMI, kg/m<sup>2</sup></td></tr><tr><td colspan="1" rowspan="1"> &lt; 24</td><td colspan="1" rowspan="1">15</td><td colspan="1" rowspan="1">9.94 ± 1.15</td><td colspan="1" rowspan="2">NS</td></tr><tr><td colspan="1" rowspan="1"> ≥ 24</td><td colspan="1" rowspan="1">36</td><td colspan="1" rowspan="1">9.38 ± 1.10</td></tr><tr><td colspan="4" rowspan="1">FBG, mmol/l<sup><xref ref-type="table-fn" rid="table-fn7-0300060513477290">c</xref></sup></td></tr><tr><td colspan="1" rowspan="1"> ≤ 7.0</td><td colspan="1" rowspan="1">15</td><td colspan="1" rowspan="1">9.76 ± 1.15</td><td colspan="1" rowspan="2">NS</td></tr><tr><td colspan="1" rowspan="1"> &gt; 7.0</td><td colspan="1" rowspan="1">35</td><td colspan="1" rowspan="1">9.48 ± 1.13</td></tr><tr><td colspan="4" rowspan="1">HbA<sub>1c</sub>, %<sup><xref ref-type="table-fn" rid="table-fn8-0300060513477290">d</xref></sup></td></tr><tr><td colspan="1" rowspan="1"> &lt; 6.5</td><td colspan="1" rowspan="1">3</td><td colspan="1" rowspan="1">9.75 ± 0.84</td><td colspan="1" rowspan="3">NS</td></tr><tr><td colspan="1" rowspan="1"> 6.5–7.0</td><td colspan="1" rowspan="1">4</td><td colspan="1" rowspan="1">9.95 ± 1.51</td></tr><tr><td colspan="1" rowspan="1"> &gt; 7.0</td><td colspan="1" rowspan="1">32</td><td colspan="1" rowspan="1">9.53 ± 1.13</td></tr></tbody></table><table-wrap-foot><fn id="table-fn4-0300060513477290"><p>Data presented as mean ± SD.</p></fn><fn id="table-fn5-0300060513477290"><label>a</label><p><italic>P</italic> &lt; 0.05; continuous variables between the subgroups were compared using an unpaired Student’s <italic>t</italic>-test; categorical variables were compared between the subgroups using χ<sup>2</sup>-test.</p></fn><fn id="table-fn6-0300060513477290"><label>b</label><p>Only 50 patients had total cholesterol data.</p></fn><fn id="table-fn7-0300060513477290"><label>c</label><p>Only 50 patients had FBG data.</p></fn><fn id="table-fn8-0300060513477290"><label>d</label><p>Only 39 patients had HbA<sub>1c</sub> data.</p></fn><fn id="table-fn9-0300060513477290"><p>TC, total cholesterol; BMI, body mass index; FBG, fasting blood glucose; HbA<sub>1c</sub>, glycosylated haemoglobin; NS, not statistically significant (<italic>P</italic> ≥ 0.05).</p></fn></table-wrap-foot></table-wrap></p><p>Univariate linear regression analyses showed a significant correlation between age and increased CAVI (<italic>P</italic> &lt; 0.001; <xref ref-type="table" rid="table3-0300060513477290">Table 3</xref>). Multivariate linear regression analyses demonstrated that age was the only significant factor influencing the CAVI score in patients with type 2 diabetes (odds ratio = 2.145; 95% Wald confidence limit = 11.971; <italic>P</italic> = 0.0002).<table-wrap id="table3-0300060513477290" position="float"><label>Table 3.</label><caption><p>Univariate linear regression analyses of the association between clinical parameters and cardio–ankle vascular index (CAVI) scores for patients with type 2 diabetes mellitus (<italic>n</italic> = 51).</p></caption><graphic alt-version="no" alternate-form-of="table3-0300060513477290" position="float" xlink:href="10.1177_0300060513477290-table3.tif" xlink:type="simple"/><table frame="hsides"><thead align="left"><tr><th colspan="1" rowspan="2">Parameter</th><th colspan="2" rowspan="1">CAVI score</th><th colspan="1" rowspan="2">Statistical significance</th></tr><tr><th colspan="1" rowspan="1">≤ 9.1</th><th colspan="1" rowspan="1">&gt; 9.1</th></tr></thead><tbody align="left"><tr><td colspan="4" rowspan="1">Sex</td></tr><tr><td colspan="1" rowspan="1"> Male</td><td colspan="1" rowspan="1">11 (52.4)</td><td colspan="1" rowspan="1">18 (60.0)</td><td colspan="1" rowspan="2">NS</td></tr><tr><td colspan="1" rowspan="1"> Female</td><td colspan="1" rowspan="1">10 (47.6)</td><td colspan="1" rowspan="1">12 (40.0)</td></tr><tr><td colspan="4" rowspan="1">Age, years</td></tr><tr><td colspan="1" rowspan="1"> &lt; 50</td><td colspan="1" rowspan="1">2 (9.5)</td><td colspan="1" rowspan="1">0 (0.0)</td><td colspan="1" rowspan="4"><italic>P</italic> &lt; 0.001</td></tr><tr><td colspan="1" rowspan="1"> 50–59</td><td colspan="1" rowspan="1">10 (47.6)</td><td colspan="1" rowspan="1">3 (10.0)</td></tr><tr><td colspan="1" rowspan="1"> 60–69</td><td colspan="1" rowspan="1">5 (23.8)</td><td colspan="1" rowspan="1">6 (20.0)</td></tr><tr><td colspan="1" rowspan="1"> ≥ 70</td><td colspan="1" rowspan="1">4 (19.0)</td><td colspan="1" rowspan="1">21 (70.0)</td></tr><tr><td colspan="4" rowspan="1">Smoking history</td></tr><tr><td colspan="1" rowspan="1"> No</td><td colspan="1" rowspan="1">7 (33.3)</td><td colspan="1" rowspan="1">4 (13.3)</td><td colspan="1" rowspan="2">NS</td></tr><tr><td colspan="1" rowspan="1"> Yes</td><td colspan="1" rowspan="1">14 (66.7)</td><td colspan="1" rowspan="1">26 (86.7)</td></tr><tr><td colspan="4" rowspan="1">Alcohol history</td></tr><tr><td colspan="1" rowspan="1"> No</td><td colspan="1" rowspan="1">17 (81.0)</td><td colspan="1" rowspan="1">27 (90.0)</td><td colspan="1" rowspan="2">NS</td></tr><tr><td colspan="1" rowspan="1"> Yes</td><td colspan="1" rowspan="1">4 (19.0)</td><td colspan="1" rowspan="1">3 (10.0)</td></tr><tr><td colspan="4" rowspan="1">Hypertension</td></tr><tr><td colspan="1" rowspan="1"> No</td><td colspan="1" rowspan="1">3 (14.3)</td><td colspan="1" rowspan="1">4 (13.3)</td><td colspan="1" rowspan="2">NS</td></tr><tr><td colspan="1" rowspan="1"> Yes</td><td colspan="1" rowspan="1">18 (85.7)</td><td colspan="1" rowspan="1">26 (86.7)</td></tr><tr><td colspan="4" rowspan="1">Coronary heart disease</td></tr><tr><td colspan="1" rowspan="1"> No</td><td colspan="1" rowspan="1">12 (57.1)</td><td colspan="1" rowspan="1">14 (46.7)</td><td colspan="1" rowspan="2">NS</td></tr><tr><td colspan="1" rowspan="1"> Yes</td><td colspan="1" rowspan="1">9 (42.9)</td><td colspan="1" rowspan="1">16 (53.3)</td></tr><tr><td colspan="4" rowspan="1">TC, mmol/l<sup><xref ref-type="table-fn" rid="table-fn11-0300060513477290">a</xref></sup></td></tr><tr><td colspan="1" rowspan="1"> &lt; 5.2</td><td colspan="1" rowspan="1">15 (75.0)</td><td colspan="1" rowspan="1">19 (63.3)</td><td colspan="1" rowspan="2">NS</td></tr><tr><td colspan="1" rowspan="1"> ≥ 5.2</td><td colspan="1" rowspan="1">5 (25.0)</td><td colspan="1" rowspan="1">11 (36.7)</td></tr><tr><td colspan="4" rowspan="1">BMI, kg/m<sup>2</sup></td></tr><tr><td colspan="1" rowspan="1"> &lt; 24</td><td colspan="1" rowspan="1">4 (19.0)</td><td colspan="1" rowspan="1">11 (36.7)</td><td colspan="1" rowspan="2">NS</td></tr><tr><td colspan="1" rowspan="1"> ≥ 24</td><td colspan="1" rowspan="1">17 (81.0)</td><td colspan="1" rowspan="1">19 (63.3)</td></tr><tr><td colspan="4" rowspan="1">FBG, mmol/l<sup><xref ref-type="table-fn" rid="table-fn12-0300060513477290">b</xref></sup></td></tr><tr><td colspan="1" rowspan="1"> ≤ 7.0</td><td colspan="1" rowspan="1">5 (25.0)</td><td colspan="1" rowspan="1">10 (33.3)</td><td colspan="1" rowspan="2">NS</td></tr><tr><td colspan="1" rowspan="1"> &gt; 7.0</td><td colspan="1" rowspan="1">15 (75.0)</td><td colspan="1" rowspan="1">20 (66.7)</td></tr><tr><td colspan="4" rowspan="1">HbA<sub>1c,</sub> %<sup><xref ref-type="table-fn" rid="table-fn13-0300060513477290">c</xref></sup></td></tr><tr><td colspan="1" rowspan="1"> &lt; 6.5%</td><td colspan="1" rowspan="1">1 (6.3)</td><td colspan="1" rowspan="1">2 (8.7)</td><td colspan="1" rowspan="3">NS</td></tr><tr><td colspan="1" rowspan="1"> 6.5–7.0%</td><td colspan="1" rowspan="1">2 (12.5)</td><td colspan="1" rowspan="1">2 (8.7)</td></tr><tr><td colspan="1" rowspan="1"> &gt; 7.0%</td><td colspan="1" rowspan="1">13 (81.3)</td><td colspan="1" rowspan="1">19 (82.6)</td></tr></tbody></table><table-wrap-foot><fn id="table-fn10-0300060513477290"><p>Data presented as <italic>n</italic> (%) of patients.</p></fn><fn id="table-fn11-0300060513477290"><label>a</label><p>Only 50 patients had TC data.</p></fn><fn id="table-fn12-0300060513477290"><label>b</label><p>Only 50 patients had FBG data.</p></fn><fn id="table-fn13-0300060513477290"><label>c</label><p>Only 39 patients had HbA<sub>1c</sub> data.</p></fn><fn id="table-fn14-0300060513477290"><p>TC, total cholesterol; BMI, body mass index; FBG, fasting blood glucose; HbA<sub>1c</sub>, glycosylated haemoglobin; NS, not statistically significant (<italic>P</italic> ≥ 0.05).</p></fn></table-wrap-foot></table-wrap></p></sec><sec id="sec8-0300060513477290" sec-type="discussion"><title>Discussion</title><p>The present study demonstrated that arterial stiffness, as indicated by an elevated CAVI score, was more common in patients with type 2 diabetes than in age-matched nondiabetic patients; and increasing age was significantly correlated with an increased CAVI score. These findings suggest that arterial stiffening may increase with age in patients with type 2 diabetes, potentially increasing the risk of cardiovascular complications. Therefore, clinicians should carefully evaluate older patients with type 2 diabetes for cardiovascular complications, particularly those aged ≥ 70 years.</p><p>Increased arterial stiffness is common in patients with type 2 diabetes,<sup><xref ref-type="bibr" rid="bibr27-0300060513477290">27</xref></sup> with microvascular complications commonly revealed by PWV.<sup><xref ref-type="bibr" rid="bibr28-0300060513477290">28</xref></sup> Contemporary CAVI methodology provides a less technically challenging<sup><xref ref-type="bibr" rid="bibr12-0300060513477290">12</xref></sup> and more accurate measurement tool for identifying arterial stiffening, compared with PWV.<sup><xref ref-type="bibr" rid="bibr29-0300060513477290">29</xref><xref ref-type="bibr" rid="bibr30-0300060513477290"/><xref ref-type="bibr" rid="bibr31-0300060513477290"/><xref ref-type="bibr" rid="bibr32-0300060513477290"/>–<xref ref-type="bibr" rid="bibr33-0300060513477290">33</xref></sup> Furthermore, variations in blood pressure and clinical abnormalities may result in inaccuracies in PWV, but not in CAVI.<sup><xref ref-type="bibr" rid="bibr34-0300060513477290">34</xref></sup> CAVI scoring, developed in 2004, was originally limited by the absence of sex- and age-appropriate baselines for healthy patients.<sup><xref ref-type="bibr" rid="bibr35-0300060513477290">35</xref></sup> As these baselines are now available,<sup><xref ref-type="bibr" rid="bibr12-0300060513477290">12</xref></sup> CAVI scoring can be employed as an easy, effective, and accurate measure of arterial stiffness in patients with, or without, type 2 diabetes.</p><p>The CAVI scores were significantly higher in patients with type 2 diabetes compared with the age-matched nondiabetic patients in the current study. Patients with type 2 diabetes have also demonstrated higher CAVI scores when they also present with diabetic peripheral neuropathy,<sup><xref ref-type="bibr" rid="bibr36-0300060513477290">36</xref></sup> microvascular conditions,<sup><xref ref-type="bibr" rid="bibr14-0300060513477290">14</xref></sup> intima–media thickening,<sup><xref ref-type="bibr" rid="bibr32-0300060513477290">32</xref></sup> carotid beta stiffness,<sup><xref ref-type="bibr" rid="bibr32-0300060513477290">32</xref></sup> and carotid plaques.<sup><xref ref-type="bibr" rid="bibr6-0300060513477290">6</xref>,<xref ref-type="bibr" rid="bibr32-0300060513477290">32</xref></sup> Thus, CAVI may be particularly useful in the early identification cardiovascular complications, in high-risk patients with type 2 diabetes.</p><p>Elevated CAVI scores in patients with type 2 diabetes were most closely associated with increasing age (CAVI scores &gt; 9.1 in 58.8% of patients), which is consistent with previous findings.<sup><xref ref-type="bibr" rid="bibr26-0300060513477290">26</xref>,<xref ref-type="bibr" rid="bibr32-0300060513477290">32</xref></sup> While increasing age was the most significant clinical variable to be associated with an elevated CAVI score (<italic>P</italic> = 0.002; <xref ref-type="table" rid="table2-0300060513477290">Table 2</xref>), these preliminary findings also identified smoking and elevated total cholesterol levels (≥ 5.2 mmol/l) as other risk factors for an elevated CAVI, and an inverse relationship was observed between alcohol consumption and the CAVI score, although further study of such factors will be required. Relationships between arterial stiffness and age, sex and type 1 diabetes mellitus have also been reported.<sup><xref ref-type="bibr" rid="bibr37-0300060513477290">37</xref></sup> In the current study, no significant relationship between sex and CAVI score was observed, which may reflect the sample size or individual patient pathophysiology. Further investigations of these risk factors, in larger cohorts of more varied ethnic and geographical populations, are required.</p><p>Patients with type 2 diabetes often exhibit hyperlipidaemia, resulting in diabetic dyslipidaemia being a well-recognized and modifiable risk factor for cardiovascular conditions.<sup><xref ref-type="bibr" rid="bibr38-0300060513477290">38</xref></sup> In a study of 2383 individuals, cardiovascular symptoms appeared at a mean age of 62 years in patients with type 2 diabetes, resulting in a recommendation that patients aged &gt; 40 years undergo regular cardiovascular evaluation.<sup><xref ref-type="bibr" rid="bibr38-0300060513477290">38</xref></sup> These findings support the implementation of screening during midlife to improve the early detection of cardiovascular complications. The association with hyperlipidaemia suggests a mechanistic relationship, in which a sustained plasma lipid abnormality impacts on cardiovascular function and increases CAVI, requiring further investigation of the processes and pathways involved. Based on univariate linear regression analyses in the current study, however, the CAVI score was not significantly associated with the total cholesterol concentration.</p><p>The prevalence and impact of hypertension increases with age, affecting &gt; 40% of older men and women.<sup><xref ref-type="bibr" rid="bibr39-0300060513477290">39</xref></sup> The current study considered hypertension and age as separate risk factors for an elevated CAVI score, but hypertension is known to increase with age. Serum resistin, an adipocyte- and monocyte-derived cytokine, has been shown to have a positive correlation with cardiovascular abnormalities in patients with type 2 diabetes, including hypertension,<sup><xref ref-type="bibr" rid="bibr40-0300060513477290">40</xref></sup> suggesting that older patients at greater hypertension risk are also at higher cardiovascular risk. In the current study, blood-pressure analysis suggested no direct correlation with increased CAVI; however, further studies may identify relationships between age and hypertension, in certain groups. Similarly, a recent report from EURODIAB showed that the increased formation of advanced glycation endproducts in patients with type 1 diabetes was associated with postprandial blood sugar magnitude, a parameter implicated in arterial stiffening.<sup><xref ref-type="bibr" rid="bibr38-0300060513477290">38</xref></sup> Thus, sustained abnormal blood parameters (postprandial blood sugar magnitude or hypertension) may promote progressive arterial stiffening by altering the composition of the vascular walls, resulting in heightened risks in patients with longer exposure (i.e. greater age).</p><p>In conclusion, the current study demonstrated that patients with type 2 diabetes had an increased risk of arterial stiffness based on the CAVI score, compared with age-matched nondiabetic patients, which could in turn increase their risk of developing other cardiovascular complications. Furthermore, advanced age was associated with an elevated CAVI score. Consistent with previous studies, these findings suggest that clinicians should carefully evaluate older patients with type 2 diabetes for arterial stiffening indicative of progressive cardiovascular disease.</p></sec></body><back><ack><title>Acknowledgements</title><p>The Authors thank Dr Minghai Li from the Department of Medical Engineering, General Hospital of Beijing Military Command, Beijing, China for providing valuable suggestions on the development of CAVI evaluations.</p></ack><sec id="sec13-0300060513477290"><title>Declaration of conflicting interest</title><p>The Authors declares that there are no conflicts of interest.</p></sec><sec id="sec14-0300060513477290"><title>Funding</title><p>This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.</p></sec><ref-list><title>References</title><ref id="bibr1-0300060513477290"><label>1</label><citation citation-type="journal" xlink:type="simple"><person-group person-group-type="author"><name name-style="western"><surname>Khang</surname><given-names>YH</given-names></name><name name-style="western"><surname>Cho</surname><given-names>SI</given-names></name><name name-style="western"><surname>Kim</surname><given-names>HR</given-names></name></person-group>. <article-title>Risks for cardiovascular disease, stroke, ischaemic heart disease, and diabetes mellitus associated with the metabolic syndrome using the new harmonised definition: findings from nationally representative longitudinal data from an Asian population</article-title>. <source>Atherosclerosis</source> <year>2010</year>; <volume>213</volume>: <fpage>579</fpage>–<lpage>585</lpage>.</citation></ref><ref id="bibr2-0300060513477290"><label>2</label><citation citation-type="journal" xlink:type="simple"><person-group person-group-type="author"><name name-style="western"><surname>Grupo de Trabajo Diabetes Mellitus</surname><given-names>Y</given-names></name></person-group>. <collab xlink:type="simple">Enfermedad Cardiovascular de la Sociedad Española de Diabetes</collab>. <article-title>Diabetes mellitus and cardiovascular risk. Recommendations of the Working Group of Diabetes Mellitus and Cardiovascular Disease of the Spanish Diabetes Society 2009</article-title>. <source>Endocrinol Nutr</source> <year>2010</year>; <volume>57</volume>: <fpage>220</fpage>–<lpage>226</lpage>. <comment>[in Spanish]</comment>.</citation></ref><ref id="bibr3-0300060513477290"><label>3</label><citation citation-type="journal" xlink:type="simple"><person-group person-group-type="author"><name name-style="western"><surname>Henry</surname><given-names>RR</given-names></name></person-group>. <article-title>Preventing cardiovascular complications of type 2 diabetes: focus on lipid management</article-title>. <source>Clin Diabetes</source> <year>2001</year>; <volume>19</volume>: <fpage>113</fpage>–<lpage>120</lpage>.</citation></ref><ref id="bibr4-0300060513477290"><label>4</label><citation citation-type="journal" xlink:type="simple"><person-group person-group-type="author"><name name-style="western"><surname>Nickenig</surname><given-names>G</given-names></name><name name-style="western"><surname>Röling</surname><given-names>J</given-names></name><name name-style="western"><surname>Strehlow</surname><given-names>K</given-names></name><etal/></person-group>. <article-title>Insulin induces upregulation of vascular AT<sub>1</sub> receptor gene expression by posttranscriptional mechanisms</article-title>. <source>Circulation</source> <year>1998</year>; <volume>98</volume>: <fpage>2453</fpage>–<lpage>2460</lpage>.</citation></ref><ref id="bibr5-0300060513477290"><label>5</label><citation citation-type="journal" xlink:type="simple"><person-group person-group-type="author"><name name-style="western"><surname>Jesmin</surname><given-names>S</given-names></name><name name-style="western"><surname>Sakuma</surname><given-names>I</given-names></name><name name-style="western"><surname>Hattori</surname><given-names>Y</given-names></name><etal/></person-group>. <article-title>Role of angiotensin II in altered expression of molecules responsible for coronary matrix remodeling in insulin-resistant diabetic rats</article-title>. <source>Arterioscler Thromb Vasc Biol</source> <year>2003</year>; <volume>23</volume>: <fpage>2021</fpage>–<lpage>2026</lpage>.</citation></ref><ref id="bibr6-0300060513477290"><label>6</label><citation citation-type="journal" xlink:type="simple"><person-group person-group-type="author"><name name-style="western"><surname>Rizzoni</surname><given-names>D</given-names></name><name name-style="western"><surname>Porteri</surname><given-names>E</given-names></name><name name-style="western"><surname>Guelfi</surname><given-names>D</given-names></name><etal/></person-group>. <article-title>Structural alterations in subcutaneous small arteries of normotensive and hypertensive patients with non-insulin-dependent diabetes mellitus</article-title>. <source>Circulation</source> <year>2001</year>; <volume>103</volume>: <fpage>1238</fpage>–<lpage>1244</lpage>.</citation></ref><ref id="bibr7-0300060513477290"><label>7</label><citation citation-type="journal" xlink:type="simple"><person-group person-group-type="author"><name name-style="western"><surname>Brownlee</surname><given-names>M</given-names></name><name name-style="western"><surname>Cerami</surname><given-names>A</given-names></name><name name-style="western"><surname>Vlassara</surname><given-names>H</given-names></name></person-group>. <article-title>Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications</article-title>. <source>New Engl J Med</source> <year>1988</year>; <volume>318</volume>: <fpage>1315</fpage>–<lpage>1321</lpage>.</citation></ref><ref id="bibr8-0300060513477290"><label>8</label><citation citation-type="journal" xlink:type="simple"><person-group person-group-type="author"><name name-style="western"><surname>Laurent</surname><given-names>S</given-names></name><name name-style="western"><surname>Boutouyrie</surname><given-names>P</given-names></name><name name-style="western"><surname>Asmar</surname><given-names>R</given-names></name><etal/></person-group>. <article-title>Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients</article-title>. <source>Hypertension</source> <year>2001</year>; <volume>37</volume>: <fpage>1236</fpage>–<lpage>1241</lpage>.</citation></ref><ref id="bibr9-0300060513477290"><label>9</label><citation citation-type="journal" xlink:type="simple"><person-group person-group-type="author"><name name-style="western"><surname>Cruickshank</surname><given-names>K</given-names></name><name name-style="western"><surname>Riste</surname><given-names>L</given-names></name><name name-style="western"><surname>Anderson</surname><given-names>SG</given-names></name><etal/></person-group>. <article-title>Aortic pulse-wave velocity and its relationship to mortality in diabetes and glucose intolerance: an integrated index of vascular function?</article-title> <source>Circulation</source> <year>2002</year>; <volume>106</volume>: <fpage>2085</fpage>–<lpage>2090</lpage>.</citation></ref><ref id="bibr10-0300060513477290"><label>10</label><citation citation-type="journal" xlink:type="simple"><person-group person-group-type="author"><name name-style="western"><surname>Strain</surname><given-names>WD</given-names></name><name name-style="western"><surname>Chaturvedi</surname><given-names>N</given-names></name><name name-style="western"><surname>Dockery</surname><given-names>F</given-names></name><etal/></person-group>. <article-title>Increased arterial stiffness in Europeans and African Caribbeans with type 2 diabetes cannot be accounted for by conventional cardiovascular risk factors</article-title>. <source>Am J Hypertens</source> <year>2006</year>; <volume>19</volume>: <fpage>889</fpage>–<lpage>896</lpage>.</citation></ref><ref id="bibr11-0300060513477290"><label>11</label><citation citation-type="journal" xlink:type="simple"><person-group person-group-type="author"><name name-style="western"><surname>Takeno</surname><given-names>K</given-names></name><name name-style="western"><surname>Mita</surname><given-names>T</given-names></name><name name-style="western"><surname>Nakayama</surname><given-names>S</given-names></name><etal/></person-group>. <article-title>Masked hypertension, endothelial dysfunction, and arterial stiffness in type 2 diabetes mellitus: a pilot study</article-title>. <source>Am J Hypertens</source> <year>2012</year>; <volume>25</volume>: <fpage>165</fpage>–<lpage>170</lpage>.</citation></ref><ref id="bibr12-0300060513477290"><label>12</label><citation citation-type="journal" xlink:type="simple"><person-group person-group-type="author"><name name-style="western"><surname>Namekata</surname><given-names>T</given-names></name><name name-style="western"><surname>Suzuki</surname><given-names>K</given-names></name><name name-style="western"><surname>Ishizuka</surname><given-names>N</given-names></name><etal/></person-group>. <article-title>Establishing baseline criteria of cardio-ankle vascular index as a new indicator of arteriosclerosis: a cross-sectional study</article-title>. <source>BMC Cardiovasc Disord</source> <year>2011</year>; <volume>11</volume>: <fpage>51</fpage>–<lpage>51</lpage>.</citation></ref><ref id="bibr13-0300060513477290"><label>13</label><citation citation-type="journal" xlink:type="simple"><person-group person-group-type="author"><name name-style="western"><surname>Kawasaki</surname><given-names>T</given-names></name><name name-style="western"><surname>Sasayama</surname><given-names>S</given-names></name><name name-style="western"><surname>Yagi</surname><given-names>S</given-names></name><etal/></person-group>. <article-title>Non-invasive assessment of the age related changes in stiffness of major branches of the human arteries</article-title>. <source>Cardiovasc Res</source> <year>1987</year>; <volume>21</volume>: <fpage>678</fpage>–<lpage>687</lpage>.</citation></ref><ref id="bibr14-0300060513477290"><label>14</label><citation citation-type="journal" xlink:type="simple"><person-group person-group-type="author"><name name-style="western"><surname>Kim</surname><given-names>KJ</given-names></name><name name-style="western"><surname>Lee</surname><given-names>BW</given-names></name><name name-style="western"><surname>Kim</surname><given-names>HM</given-names></name><etal/></person-group>. <article-title>Associations between cardio-ankle vascular index and microvascular complications in type 2 diabetes mellitus patients</article-title>. <source>J Atheroscler Thromb</source> <year>2011</year>; <volume>18</volume>: <fpage>328</fpage>–<lpage>336</lpage>.</citation></ref><ref id="bibr15-0300060513477290"><label>15</label><citation citation-type="journal" xlink:type="simple"><person-group person-group-type="author"><name name-style="western"><surname>Takaki</surname><given-names>A</given-names></name><name name-style="western"><surname>Ogawa</surname><given-names>H</given-names></name><name name-style="western"><surname>Wakeyama</surname><given-names>T</given-names></name><etal/></person-group>. <article-title>Cardio-ankle vascular index is superior to brachial-ankle pulse wave velocity as an index of arterial stiffness</article-title>. <source>Hypertens Res</source> <year>2008</year>; <volume>31</volume>: <fpage>1347</fpage>–<lpage>1355</lpage>.</citation></ref><ref id="bibr16-0300060513477290"><label>16</label><citation citation-type="journal" xlink:type="simple"><person-group person-group-type="author"><name name-style="western"><surname>Miyoshi</surname><given-names>T</given-names></name><name name-style="western"><surname>Doi</surname><given-names>M</given-names></name><name name-style="western"><surname>Hirohata</surname><given-names>S</given-names></name><etal/></person-group>. <article-title>Cardio-ankle vascular index is independently associated with the severity of coronary atherosclerosis and left ventricular function in patients with ischemic heart disease</article-title>. <source>J Atheroscler Thromb</source> <year>2010</year>; <volume>17</volume>: <fpage>249</fpage>–<lpage>258</lpage>.</citation></ref><ref id="bibr17-0300060513477290"><label>17</label><citation citation-type="journal" xlink:type="simple"><person-group person-group-type="author"><name name-style="western"><surname>Lee</surname><given-names>JA</given-names></name><name name-style="western"><surname>Kim</surname><given-names>DH</given-names></name><name name-style="western"><surname>Yu</surname><given-names>SJ</given-names></name><etal/></person-group>. <article-title>Association of serum albumin and homocysteine levels and cardio-ankle vascular index in patients with continuous ambulatory peritoneal dialysis</article-title>. <source>Korean J Intern Med</source> <year>2006</year>; <volume>21</volume>: <fpage>33</fpage>–<lpage>38</lpage>.</citation></ref><ref id="bibr18-0300060513477290"><label>18</label><citation citation-type="journal" xlink:type="simple"><person-group person-group-type="author"><name name-style="western"><surname>Mineoka</surname><given-names>Y</given-names></name><name name-style="western"><surname>Fukui</surname><given-names>M</given-names></name><name name-style="western"><surname>Tanaka</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>Relationship between cardio-ankle vascular index (CAVI) and coronary artery calcification (CAC) in patients with type 2 diabetes mellitus</article-title>. <source>Heart Vessels</source> <year>2012</year>; <volume>27</volume>: <fpage>160</fpage>–<lpage>165</lpage>.</citation></ref><ref id="bibr19-0300060513477290"><label>19</label><citation citation-type="journal" xlink:type="simple"><person-group person-group-type="author"><name name-style="western"><surname>Nagayama</surname><given-names>D</given-names></name><name name-style="western"><surname>Saiki</surname><given-names>A</given-names></name><name name-style="western"><surname>Endo</surname><given-names>K</given-names></name><etal/></person-group>. <article-title>Improvement of cardio-ankle vascular index by glimepiride in type 2 diabetic patients</article-title>. <source>Int J Clin Pract</source> <year>2010</year>; <volume>64</volume>: <fpage>1796</fpage>–<lpage>1801</lpage>.</citation></ref><ref id="bibr20-0300060513477290"><label>20</label><citation citation-type="journal" xlink:type="simple"><person-group person-group-type="author"><name name-style="western"><surname>Genuth</surname><given-names>S</given-names></name><name name-style="western"><surname>Alberti</surname><given-names>KG</given-names></name><name name-style="western"><surname>Bennett</surname><given-names>P</given-names></name><etal/></person-group>. <article-title>Follow-up report on the diagnosis of diabetes mellitus</article-title>. <source>Diabetes Care</source> <year>2003</year>; <volume>26</volume>: <fpage>3160</fpage>–<lpage>3167</lpage>.</citation></ref><ref id="bibr21-0300060513477290"><label>21</label><citation citation-type="journal" xlink:type="simple"><person-group person-group-type="author"><name name-style="western"><surname>Chalmers</surname><given-names>J</given-names></name></person-group>. <article-title>The 1999 WHO–ISH Guidelines for the Management of Hypertension</article-title>. <source>Med J Aust</source> <year>1999</year>; <volume>171</volume>: <fpage>458</fpage>–<lpage>459</lpage>.</citation></ref><ref id="bibr22-0300060513477290"><label>22</label><citation citation-type="journal" xlink:type="simple"><collab xlink:type="simple">Nomenclature and criteria for diagnosis of ischemic heart disease</collab>. <article-title>Report of the Joint International Society and Federation of Cardiology/World Health Organization Task Force on Standardization of Clinical Nomenclature</article-title>. <source>Circulation</source> <year>1979</year>; <volume>59</volume>: <fpage>607</fpage>–<lpage>609</lpage>.</citation></ref><ref id="bibr23-0300060513477290"><label>23</label><citation citation-type="journal" xlink:type="simple"><person-group person-group-type="author"><name name-style="western"><surname>Friedewald</surname><given-names>WT</given-names></name><name name-style="western"><surname>Levy</surname><given-names>RI</given-names></name><name name-style="western"><surname>Fredrickson</surname><given-names>DS</given-names></name></person-group>. <article-title>Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge</article-title>. <source>Clin Chem</source> <year>1972</year>; <volume>18</volume>: <fpage>499</fpage>–<lpage>502</lpage>.</citation></ref><ref id="bibr24-0300060513477290"><label>24</label><citation citation-type="journal" xlink:type="simple"><person-group person-group-type="author"><name name-style="western"><surname>Matthews</surname><given-names>DR</given-names></name><name name-style="western"><surname>Hosker</surname><given-names>JP</given-names></name><name name-style="western"><surname>Rudenski</surname><given-names>AS</given-names></name><etal/></person-group>. <article-title>Homeostasis model assessment: insulin resistance and <italic>β</italic>-cell function from fasting plasma glucose and insulin concentrations in man</article-title>. <source>Diabetologia</source> <year>1985</year>; <volume>28</volume>: <fpage>412</fpage>–<lpage>419</lpage>.</citation></ref><ref id="bibr25-0300060513477290"><label>25</label><citation citation-type="journal" xlink:type="simple"><person-group person-group-type="author"><name name-style="western"><surname>Kubozono</surname><given-names>T</given-names></name><name name-style="western"><surname>Miyata</surname><given-names>M</given-names></name><name name-style="western"><surname>Ueyama</surname><given-names>K</given-names></name><etal/></person-group>. <article-title>Clinical significance and reproducibility of new arterial distensibility index</article-title>. <source>Circ J</source> <year>2007</year>; <volume>71</volume>: <fpage>89</fpage>–<lpage>94</lpage>.</citation></ref><ref id="bibr26-0300060513477290"><label>26</label><citation citation-type="journal" xlink:type="simple"><person-group person-group-type="author"><name name-style="western"><surname>Shirai</surname><given-names>K</given-names></name><name name-style="western"><surname>Utino</surname><given-names>J</given-names></name><name name-style="western"><surname>Otsuka</surname><given-names>K</given-names></name><etal/></person-group>. <article-title>A novel blood pressure-independent arterial wall stiffness parameter; cardio-ankle vascular index (CAVI)</article-title>. <source>J Atheroscler Thromb</source> <year>2006</year>; <volume>13</volume>: <fpage>101</fpage>–<lpage>107</lpage>.</citation></ref><ref id="bibr27-0300060513477290"><label>27</label><citation citation-type="journal" xlink:type="simple"><person-group person-group-type="author"><name name-style="western"><surname>Wakabayashi</surname><given-names>I</given-names></name><name name-style="western"><surname>Masuda</surname><given-names>H</given-names></name></person-group>. <article-title>Association of acute-phase reactants with arterial stiffness in patients with type 2 diabetes mellitus</article-title>. <source>Clin Chim Acta</source> <year>2006</year>; <volume>365</volume>: <fpage>230</fpage>–<lpage>235</lpage>.</citation></ref><ref id="bibr28-0300060513477290"><label>28</label><citation citation-type="journal" xlink:type="simple"><person-group person-group-type="author"><name name-style="western"><surname>Cardoso</surname><given-names>CR</given-names></name><name name-style="western"><surname>Ferreira</surname><given-names>MT</given-names></name><name name-style="western"><surname>Leite</surname><given-names>NC</given-names></name><etal/></person-group>. <article-title>Microvascular degenerative complications are associated with increased aortic stiffness in type 2 diabetic patients</article-title>. <source>Atherosclerosis</source> <year>2009</year>; <volume>205</volume>: <fpage>472</fpage>–<lpage>476</lpage>.</citation></ref><ref id="bibr29-0300060513477290"><label>29</label><citation citation-type="journal" xlink:type="simple"><person-group person-group-type="author"><name name-style="western"><surname>Lyons</surname><given-names>D</given-names></name><name name-style="western"><surname>Roy</surname><given-names>S</given-names></name><name name-style="western"><surname>Patel</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>Impaired nitric oxide-mediated vasodilatation and total body nitric oxide production in healthy old age</article-title>. <source>Clin Sci (Lond)</source> <year>1997</year>; <volume>93</volume>: <fpage>519</fpage>–<lpage>525</lpage>.</citation></ref><ref id="bibr30-0300060513477290"><label>30</label><citation citation-type="journal" xlink:type="simple"><person-group person-group-type="author"><name name-style="western"><surname>Matz</surname><given-names>RL</given-names></name><name name-style="western"><surname>Schott</surname><given-names>C</given-names></name><name name-style="western"><surname>Stoclet</surname><given-names>JC</given-names></name><etal/></person-group>. <article-title>Age-related endothelial dysfunction with respect to nitric oxide, endothelium-derived hyperpolarizing factor and cyclooxygenase products</article-title>. <source>Physiol Res</source> <year>2000</year>; <volume>49</volume>: <fpage>11</fpage>–<lpage>18</lpage>.</citation></ref><ref id="bibr31-0300060513477290"><label>31</label><citation citation-type="journal" xlink:type="simple"><person-group person-group-type="author"><name name-style="western"><surname>Nakamura</surname><given-names>K</given-names></name><name name-style="western"><surname>Tomaru</surname><given-names>T</given-names></name><name name-style="western"><surname>Yamamura</surname><given-names>S</given-names></name><etal/></person-group>. <article-title>Cardio-ankle vascular index is a candidate predictor of coronary atherosclerosis</article-title>. <source>Circ J</source> <year>2008</year>; <volume>72</volume>: <fpage>598</fpage>–<lpage>604</lpage>.</citation></ref><ref id="bibr32-0300060513477290"><label>32</label><citation citation-type="journal" xlink:type="simple"><person-group person-group-type="author"><name name-style="western"><surname>Okura</surname><given-names>T</given-names></name><name name-style="western"><surname>Watanabe</surname><given-names>S</given-names></name><name name-style="western"><surname>Kurata</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>Relationship between cardio-ankle vascular index (CAVI) and carotid atherosclerosis in patients with essential hypertension</article-title>. <source>Hypertens Res</source> <year>2007</year>; <volume>30</volume>: <fpage>335</fpage>–<lpage>340</lpage>.</citation></ref><ref id="bibr33-0300060513477290"><label>33</label><citation citation-type="journal" xlink:type="simple"><person-group person-group-type="author"><name name-style="western"><surname>Yambe</surname><given-names>M</given-names></name><name name-style="western"><surname>Tomiyama</surname><given-names>H</given-names></name><name name-style="western"><surname>Hirayama</surname><given-names>Y</given-names></name><etal/></person-group>. <article-title>Arterial stiffening as a possible risk factor for both atherosclerosis and diastolic heart failure</article-title>. <source>Hypertens Res</source> <year>2004</year>; <volume>27</volume>: <fpage>625</fpage>–<lpage>631</lpage>.</citation></ref><ref id="bibr34-0300060513477290"><label>34</label><citation citation-type="journal" xlink:type="simple"><person-group person-group-type="author"><name name-style="western"><surname>Ibata</surname><given-names>J</given-names></name><name name-style="western"><surname>Sasaki</surname><given-names>H</given-names></name><name name-style="western"><surname>Kakimoto</surname><given-names>T</given-names></name><etal/></person-group>. <article-title>Cardio-ankle vascular index measures arterial wall stiffness independent of blood pressure</article-title>. <source>Diabetes Res Clin Pract</source> <year>2008</year>; <volume>80</volume>: <fpage>265</fpage>–<lpage>270</lpage>.</citation></ref><ref id="bibr35-0300060513477290"><label>35</label><citation citation-type="journal" xlink:type="simple"><person-group person-group-type="author"><name name-style="western"><surname>Yambe</surname><given-names>T</given-names></name><name name-style="western"><surname>Yoshizawa</surname><given-names>M</given-names></name><name name-style="western"><surname>Saijo</surname><given-names>Y</given-names></name><etal/></person-group>. <article-title>Brachio-ankle pulse wave velocity and cardio-ankle vascular index (CAVI)</article-title>. <source>Biomed Pharmacother</source> <year>2004</year>; <volume>58</volume>(<issue>suppl 1</issue>): <fpage>S95</fpage>–<lpage>S98</lpage>.</citation></ref><ref id="bibr36-0300060513477290"><label>36</label><citation citation-type="journal" xlink:type="simple"><person-group person-group-type="author"><name name-style="western"><surname>Kim</surname><given-names>ES</given-names></name><name name-style="western"><surname>Moon</surname><given-names>SD</given-names></name><name name-style="western"><surname>Kim</surname><given-names>HS</given-names></name><etal/></person-group>. <article-title>Diabetic peripheral neuropathy is associated with increased arterial stiffness without changes in carotid intima–media thickness in type 2 diabetes</article-title>. <source>Diabetes Care</source> <year>2011</year>; <volume>34</volume>: <fpage>1403</fpage>–<lpage>1405</lpage>.</citation></ref><ref id="bibr37-0300060513477290"><label>37</label><citation citation-type="journal" xlink:type="simple"><person-group person-group-type="author"><name name-style="western"><surname>Izuhara</surname><given-names>M</given-names></name><name name-style="western"><surname>Shioji</surname><given-names>K</given-names></name><name name-style="western"><surname>Kadota</surname><given-names>S</given-names></name><etal/></person-group>. <article-title>Relationship of cardio-ankle vascular index (CAVI) to carotid and coronary arteriosclerosis</article-title>. <source>Circ J</source> <year>2008</year>; <volume>72</volume>: <fpage>1762</fpage>–<lpage>1767</lpage>.</citation></ref><ref id="bibr38-0300060513477290"><label>38</label><citation citation-type="journal" xlink:type="simple"><person-group person-group-type="author"><name name-style="western"><surname>Solano</surname><given-names>MP</given-names></name><name name-style="western"><surname>Goldberg</surname><given-names>RB</given-names></name></person-group>. <article-title>Lipid management in type 2 diabetes</article-title>. <source>Clin Diabetes</source> <year>2006</year>; <volume>24</volume>: <fpage>27</fpage>–<lpage>32</lpage>.</citation></ref><ref id="bibr39-0300060513477290"><label>39</label><citation citation-type="journal" xlink:type="simple"><person-group person-group-type="author"><name name-style="western"><surname>Vokonas</surname><given-names>PS</given-names></name><name name-style="western"><surname>Kannel</surname><given-names>WB</given-names></name><name name-style="western"><surname>Cupples</surname><given-names>LA</given-names></name></person-group>. <article-title>Epidemiology and risk of hypertension in the elderly: the Framingham Study</article-title>. <source>J Hypertens Suppl</source> <year>1988</year>; <volume>6</volume>: <fpage>S3</fpage>–<lpage>S9</lpage>.</citation></ref><ref id="bibr40-0300060513477290"><label>40</label><citation citation-type="journal" xlink:type="simple"><person-group person-group-type="author"><name name-style="western"><surname>Takata</surname><given-names>Y</given-names></name><name name-style="western"><surname>Osawa</surname><given-names>H</given-names></name><name name-style="western"><surname>Kurata</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>Hyperresistinemia is associated with coexistence of hypertension and type 2 diabetes</article-title>. <source>Hypertension</source> <year>2008</year>; <volume>51</volume>: <fpage>534</fpage>–<lpage>539</lpage>.</citation></ref></ref-list></back></article>